Abstract Details
|
Shihan Chen
PRESENTER |
Ms. Chen has nothing to disclose. |
| Abdulrahman Alkhalifa, MD | Dr. Alkhalifa has nothing to disclose. |
| No disclosure on file | |
| Elisa Cali, MD (University College London) | Dr. Cali has nothing to disclose. |
| Henry Houlden | No disclosure on file |
| Wladimir B. Pinto, MD (Universidad Federal De Sao Paulo, Neurology) | Dr. Pinto has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Nicola Carboni, MD (Ospedale Binaghi) | Dr. Carboni has nothing to disclose. |
| Nazli Basak | No disclosure on file |
| Bernard Brais, MD (Montreal Neurological Institute-Hospital) | Dr. Brais has nothing to disclose. |
| Guy A. Rouleau, MD, PhD, FAAN (Montreal Neurological Institute and Hospital) | Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
| Roberta La Piana (McGill University) | Roberta La Piana has received research support from Canadian Institute Health Research. Roberta La Piana has received research support from Ataxia Canada. Roberta La Piana has received research support from Spastic Paraplegia Foundation. Roberta La Piana has received research support from Fonds de Recherche en Santé du Quebec. Roberta La Piana has received research support from Roche Canada. Roberta La Piana has received research support from ARSACS Foundation. |